US2022144833A1PendingUtilityA1
Imidazoquinoline derivatives and their use in therapy
Assignee: GLAXOSMITHKLINE BIOLOGICALS SAPriority: Sep 7, 2016Filed: Jan 24, 2022Published: May 12, 2022
Est. expirySep 7, 2036(~10.1 yrs left)· nominal 20-yr term from priority
A61K 31/4745C07F 9/6561A61P 37/04C07D 487/14C07D 471/04
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates inter alia to novel imidazoquinoline derivatives and their use in therapy, particularly as vaccine adjuvants.
Claims
exact text as granted — not AI-modified1 . A compound of formula (VI)
R 1a represents —O—Z—H;
Z represents (C 2 -C 6 alkyleneO) q ;
q represents an integer 1 to 6;
R 2 represents H, C 1 -C 6 alkyl, C 1 -C 6 alkylamino, C 1 -C 6 alkoxy, C 3 -C 6 cycloalkylC 1 -C 6 alkyl, C 3 -C 6 cycloalkylC 1 -C 6 alkylamino, C 3 -C 6 cycloalkylC 1 -C 6 alkoxy, C 1 -C 6 alkoxyC 1 -C 6 alkyl, C 1 -C 6 alkoxyC 1 -C 6 alkylamino, C 1 -C 6 alkoxyC 1 -C 6 alkoxy; and
optionally terminally substituted with a hydroxyl, amino, —NHNH 2 , N 3 , —C≡CH, —COOH, or maleimido group;
R 3 represents C 2 -C 6 alkylene-OH, C 2 -C 6 alkylene-NH 2 , C 2 -C 5 alkenyl-CH 2 —OH or C 2 -C 5 alkenyl-CH 2 —NH 2 ;
or pharmaceutically acceptable salt thereof or a protected derivative either thereof.
2 . The compound according to claim 1 wherein R 2 represents H, C 1 -C 6 alkyl or C 1 -C 6 alkoxyC 1 -C 6 alkyl.
3 . The compound according to claim 2 wherein R 2 represents H, C 1 -C 6 alkyl or C 1 -C 3 alkoxyC 1 -C 3 alkyl;
4 . The compound according to claim 3 wherein R 2 represents H, n-butyl or CH 3 CH 2 OCH 2 —.
5 . The compound according to claim 4 wherein R 2 represents H.
6 . The compound according to claim 4 wherein R 2 represents n-butyl.
7 . The compound according to claim 4 wherein R 2 represents CH 3 CH 2 OCH 2 —.
8 . The compound according to claim 1 wherein R 3 represents C 2 -C 6 alkylene-OH.
9 . The compound according to claim 8 wherein R 3 represents —CH 2 CH 2 OH.
10 . The compound according to claim 4 wherein R 3 represents C 2 -C 6 alkylene-OH.
11 . The compound according to claim 10 wherein R 3 represents —CH 2 CH 2 OH.
12 . The compound according to claim 1 wherein q represents an integer 1 to 3.
13 . The compound according to claim 12 wherein q represents 1.
14 . The compound according to claim 12 wherein q represents 3.
15 . The compound according to claim 4 wherein q represents an integer 1 to 3.
16 . The compound according to claim 15 wherein q represents 1.
17 . The compound according to claim 15 wherein q represents 3.
18 . The compound according to claim 10 wherein q represents an integer 1 to 3.
19 . The compound according to claim 18 wherein q represents 1.
20 . The compound according to claim 18 wherein q represents 3.Join the waitlist — get patent alerts
Track US2022144833A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.